Tag Archives: Global Gene Therapy in CNS Disorder Market

Global Gene Therapy in CNS Disorder Industry to Hit a Record US$113.04 Billion by 2033, Driven by remarkable a 30% CAGR | FMI Findings

The Global Gene Therapy in CNS Disorder Industry is poised for an unprecedented surge, with projections indicating a remarkable growth trajectory. According to industry forecasts, the market is expected to achieve a value of US$ 8.2 billion in 2023, catapulting to an astounding US$ 113.04 billion by 2033. This remarkable ascent is underpinned by a …

Continue reading “Global Gene Therapy in CNS Disorder Industry to Hit a Record US$113.04 Billion by 2033, Driven by remarkable a 30% CAGR | FMI Findings”